Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non - Alcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05858138
What this trial is testing

To Explore the Effectiveness of Jing-Si Herbal Tea Against Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
Taichung Tzu Chi Hospital 108
Not applicableUnknownNCT06257732
What this trial is testing

Different Exercise Modalities in the Treatment of NAFLD and Their Impact on Myokines

Who this might be right for
NAFLDNonalcoholic Fatty Liver DiseaseFatty Liver, Nonalcoholic+1 more
Yeditepe University 144
Testing effectiveness (Phase 2)Study completedNCT04052516
What this trial is testing

A Phase 2b Study of Icosabutate in Fatty Liver Disease

Who this might be right for
Non Alcoholic Steatohepatitis (NASH)
NorthSea Therapeutics B.V. 280
Not applicableStudy completedNCT03847116
What this trial is testing

Alcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseLight-to-moderate Alcohol ConsumptionType2 Diabetes Mellitus
Ningbo No. 1 Hospital 14,014
Not applicableNot Yet RecruitingNCT06623084
What this trial is testing

Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)NASH - Nonalcoholic SteatohepatitisCirrhosis+1 more
Stefania Basili 132
Testing effectiveness (Phase 2)Ended earlyNCT02244944
What this trial is testing

Ezetimibe-Ursodiol Combination Therapy on Biomarkers of Liver Function and Sterol Balance in Subjects With NAFLD

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)
Gregory Graf, PhD 2
Not applicableStudy completedNCT06275906
What this trial is testing

Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.

Who this might be right for
NAFLDObesityIBS
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 36
Testing effectiveness (Phase 2)Study completedNCT00062764
What this trial is testing

Treating Nonalcoholic Steatohepatitis With Pioglitazone

Who this might be right for
Hepatitis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 18
Not applicableStudy completedNCT04389593
What this trial is testing

Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic SteatohepatitisLiver Fibroses+1 more
University of California, San Diego 30
Not applicableStudy completedNCT07730736
What this trial is testing

Analysis of Clinical Characteristics of Chronic Hepatitis B Combined With MAFLD in Different TCM Syndrome Types

Who this might be right for
Chronic Hepatitis BMetabolic Associated Fatty Liver Disease
Foshan Hospital of Traditional Chinese Medicine 1,000
Not applicableEnded earlyNCT00375011
What this trial is testing

Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics

Who this might be right for
Cirrhosis
Meridian Bioscience, Inc. 200
Not applicableStudy completedNCT03447964
What this trial is testing

Plasma Dihydroceramides Are Associated With Hepatic Steatosis in Type 1 and Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Groupe Hospitalier Pitie-Salpetriere 128
Not applicableWithdrawnNCT05827432
What this trial is testing

FCI Effectiveness in NAFLD Stratification

Who this might be right for
Non-Alcoholic Fatty Liver Disease
NHS Grampian
Not applicableStudy completedNCT06026293
What this trial is testing

Pharmacoeconomic Evaluation of the Cost/effectiveness Ratio of Physical Exercise on Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 58
Testing effectiveness (Phase 2)Study completedNCT02546609
What this trial is testing

The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease

Who this might be right for
NAFLD
NuSirt Biopharma 91
Testing effectiveness (Phase 2)Temporarily pausedNCT00546455
What this trial is testing

A Randomized, Double-blind Study of the Effects of Fenretinide Administered in Subjects With Obesity

Who this might be right for
ObesityInsulin Resistance
University of California, San Diego 21
Not applicableStudy completedNCT05370053
What this trial is testing

The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology

Who this might be right for
Fatty LiverNAFLD
University of Kansas Medical Center 450
Not applicableWithdrawnNCT02194894
What this trial is testing

The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
University of Southern California
Not applicableStudy completedNCT06389851
What this trial is testing

Effects of Tomato Consumption on Steatosis, Intestinal Function and Glucose and Lipid Metabolism in Subjects With NAFLD

Who this might be right for
NAFLDIBS
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 80
Not applicableStudy completedNCT04859322
What this trial is testing

The Effect of Lifestyle-induced Hepatic Steatosis on Glucagon-stimulated Amino Acid Turnover

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseGlucagon Resistance
Malte Palm Suppli, MD 20
Next Page